Original Research
Accepted on 17 Dec 2024
The Role of SASP in Ischemic Stroke: A Deep Dive into Cellular Mechanisms
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1513357
Type at least 3 characters
1,089 articles
Articles
Systematic Review
Published on 17 Dec 2024
The prevalence of obstructive sleep apnea-hypopnea syndrome in patients with multiple sclerosis: a systematic review and meta-analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1444470
- 261 views
Review
Published on 17 Dec 2024
Unraveling Alzheimer’s disease: insights from single-cell sequencing and spatial transcriptomic
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1515981
- 252 views
Perspective
Published on 13 Dec 2024
Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1514644
- 274 views
Original Research
Published on 13 Dec 2024
Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1492678
- 212 views
Original Research
Published on 11 Dec 2024
Cranial volume measurement with artificial intelligence and cognitive scales in patients with clinically isolated syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1500140
- 193 views
Original Research
Published on 11 Dec 2024
Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1482932
- 273 views
Original Research
Accepted on 10 Dec 2024
Clinical and analytical monitoring of patients with Multiple Sclerosis on anti-CD20 therapeutics: A Real-world safety profile study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1500763
- 135 views
Original Research
Published on 09 Dec 2024
MOGAD and NMOSD: insights on patients’ radiological and laboratory findings from a single UAE center
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1480723
- 383 views
Systematic Review
Published on 06 Dec 2024
Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1479476
- 487 views
Original Research
Published on 04 Dec 2024
Integrative multi-omics approach using random forest and artificial neural network models for early diagnosis and immune infiltration characterization in ischemic stroke
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1475582
- 847 views
Original Research
Accepted on 02 Dec 2024
Thalamic Volume Differentiates Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorder: MRI-based Retrospective Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1491193
Original Research
Published on 27 Nov 2024
Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1437778
- 766 views
Systematic Review
Published on 26 Nov 2024
Comparison of different exercise modalities on fatigue and muscular fitness in patients with multiple sclerosis: a systematic review with network, and dose–response meta-analyses
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1494368
- 592 views
Review
Published on 20 Nov 2024
Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1438404
- 572 views
Original Research
Published on 19 Nov 2024
Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1486659
- 619 views